Bio-Rad Laboratories Inc. CI A (BIO) News

Bio-Rad Laboratories Inc. CI A (BIO): $475.50

5.81 (+1.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BIO News Items

BIO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BIO News Highlights

  • For BIO, its 30 day story count is now at 2.
  • Over the past 1 day, the trend for BIO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • VREX are the most mentioned tickers in articles about BIO.

Latest BIO News From Around the Web

Below are the latest news stories about BIO-RAD LABORATORIES INC that investors may wish to consider to help them evaluate BIO as an investment opportunity.

VAREX IMAGING (VREX) Misses Q1 Earnings Estimates

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -27.27% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | January 31, 2023

Bio-Rad (BIO) to Report Q4 Earnings: What's in the Cards?

Sustained sales gains in terms of the Bio-Rads (BIO) process media, western blotting, Droplet Digital PCR and qPCR products are likely to drive Q4 revenues.

Yahoo | January 30, 2023

Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023

HERCULES, Calif., January 06, 2023--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the fourth quarter and full year 2022 on Thursday, February 16, 2023, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

Yahoo | January 6, 2023

Here's Why You Should Retain Bio-Rad (BIO) Stock for Now

Investors are optimistic about Bio-Rad (BIO), led by robust demand in the Life Science and Clinical Diagnostics arms.

Yahoo | January 5, 2023

Bio-Rad: How Efficient Is Its Capital Management? (NYSE:BIO)

Bio-Rad Laboratories had an equally challenging Q3. See why more evidence is needed to advocate for an immediate buy on BIO stock.

Seeking Alpha | January 4, 2023

Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference

HERCULES, Calif., January 04, 2023--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 4:30 p.m. Pacific Time. The presentation will be followed by a Q&A session with participation from Bio-Rad’s Executive Vice President and COO Andrew Last, and Execut

Yahoo | January 4, 2023

Bio-Rad (BIO) Core Diagnostic Sales Grow Amid Supply Challenges

Bio-Rad's (BIO) underlying Life Science currency-neutral core revenue growth is primarily driven by Western loading, qPCR, process media and antibody products sales.

Yahoo | December 23, 2022

High-Performance Liquid Chromatography Global Market Report 2022: Ukraine-Russia War Impact

Major players in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc, Shimadzu Corporation, Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric Company, Bio-Rad Laboratories Inc, Merck Millipore, Hitachi High-Technologies Corporation, Showa Denko K K, Gilson Inc, Phenomenex, Jasco Inc, Hamilton Company, Tosoh Corporation, YMC CO LTD, Danaher Corporation, Restek, SIELC Technologies, Trajan Scientific Australia Pty Ltd, Sartorius AG and Mitsubishi Chemical Corporation. Major players in the high-performance liquid chromatography market are Waters Corporation, Agilent Technologies Inc, Shimadzu Corporation, Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric Company, Bio-Rad Laboratories Inc, Merck Millipore, Hitachi Hig...

GlobeNewswire | December 20, 2022

Is It Too Late To Consider Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)?

Today we're going to take a look at the well-established Bio-Rad Laboratories, Inc. ( NYSE:BIO ). The company's stock...

Yahoo | December 20, 2022

Thyroid Home Test Kits Market Hitting New Highs By 2030 |Roche, Abbott Laboratories, Bio-Rad Laboratories, Siemens

The Global Thyroid Home Test Kits Market research report 2022 provides a basic overview of the industry including definitions, classifications, applications, and industry chain structure. The Thyroid Home Test Kits market report provides information regarding market size, share, trends, growth,

OpenPR | December 19, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8327 seconds.